Palantir Technologies (NYSE: PLTR) shares jumped more than 4% on Monday after Option Care Health (OPCH) chose Palantir’s Artificial Intelligence Platform (AIP) for a company-wide digital transformation.
Palantir Technologies (PLTR) and Option Care Health (NASDAQ: OPCH), the leading independent home and alternate site infusion services provider, revealed a multi-year commercial partnership. This collaboration involves utilizing Palantir’s software throughout Option Care Health to enhance patient outcomes and boost operational efficiency.
Option Care Health plans to use Palantir’s Artificial Intelligence Platform (AIP) for various purposes, including nurse scheduling, patient onboarding, purchasing optimization, and supply chain execution.
John Rademacher, President & CEO of Option Care Health, said,
“We are excited to partner with one of the innovative leaders in AI-powered software and leverage their platform and expertise to enhance our intelligent technology ecosystem focused on streamlining processes, enhancing our expertise, improving the patient experience, and optimizing clinical outcomes.”
He added,
“I believe that utilizing Palantir’s Foundry and AIP will allow us to innovate rapidly, build on best practices, and help ensure our approach to AI and Machine Learning incorporates the strongest foundations and provides strong protections and integrity for our stakeholders.”
Palantir Technologies (NYSE: PLTR), a company with a history of collaboration with some major organizations globally, has notably expanded its involvement in the healthcare sector. Their software is actively utilized in various government health entities, such as the National Institutes of Health and the National Health Service of the UK.
Alex Karp, the co-founder and CEO of Palantir Technologies, highlighted that Option Care Health is at the forefront of deploying artificial intelligence in the healthcare sector. He continued,
“We are proud to support this effort, which builds on our expanding presence in and commitment to the medical sector and will expedite and improve services to patients across the country.”
Kevin Putnam is a financial journalist and editor based in New York. He specializes in editing news and analysis related to U.S. stock market.
